Edition:
United States

Inovalon Holdings Inc (INOV.OQ)

INOV.OQ on NASDAQ Stock Exchange Global Select Market

15.00USD
15 Dec 2017
Change (% chg)

$0.30 (+2.04%)
Prev Close
$14.70
Open
$14.70
Day's High
$15.07
Day's Low
$14.70
Volume
479,954
Avg. Vol
116,549
52-wk High
$17.80
52-wk Low
$8.80

Latest Key Developments (Source: Significant Developments)

Inovalon Holdings reports Q3 earnings per share of $0.06
Wednesday, 1 Nov 2017 04:10pm EDT 

Nov 1 (Reuters) - Inovalon Holdings Inc -:Inovalon reports third quarter 2017 results.Q3 non-gaap earnings per share $0.09.Q3 earnings per share $0.06.Q3 revenue $115.9 million versus I/B/E/S view $114.9 million.Q3 earnings per share view $0.08 -- Thomson Reuters I/B/E/S.Sees Q3 2017 revenue $115.9 million.Sees Q3 2017 revenue up 10 percent.Sees FY non-gaap diluted net income per share $0.30 to $0.33‍​.  Full Article

Inovalon enters into agreement with Daiichi Sankyo Inc
Thursday, 21 Sep 2017 07:55am EDT 

Sept 21 (Reuters) - Inovalon Holdings Inc :Inovalon announces agreement with daiichi sankyo, inc. To support outcomes-based contracting.Inovalon Holdings -entered into agreement with Daiichi Sankyo to understand potential role of abuse-deterrent formulations of opioid medications.  Full Article

Inovalon Holdings says ‍UnitedHealthcare has entered into a 5-year engagement with co​
Tuesday, 12 Sep 2017 07:55am EDT 

Sept 12 (Reuters) - Inovalon Holdings Inc :Inovalon Holdings Inc - ‍UnitedHealthcare has entered into a five-year engagement with co​.  Full Article

Inovalon Holdings Q2 EPS $0.04
Wednesday, 2 Aug 2017 04:10pm EDT 

Aug 2 (Reuters) - Inovalon Holdings Inc ::Reports Q2 2017 revenue $110.6 million.Inovalon reports second quarter 2017 results.Q2 Non-GAAP earnings per share $0.08.Q2 earnings per share $0.04.Q2 revenue $110.6 million versus I/B/E/S view $108.7 million.Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S.Says‍ expect approximately 17% year-over-year revenue growth in H2 2017 at midpoint of updated guidance.​Says company expects to see double-digit year-over-year revenue growth in second half of 2017​.Inovalon Holdings inc sees ‍full-year 2017 revenue $447.1 million to $459.3 million​.FY2017 revenue view $445.8 million -- Thomson Reuters I/B/E/S.Inovalon Holdings inc sees ‍ full-year 2017 diluted net income per share $0.13 to $0.16​.FY2017 earnings per share view $0.30 -- Thomson Reuters I/B/E/S.Inovalon Holdings Inc sees ‍full-year 2017 Non-GAAP diluted net income per share $0.29 to $0.32​.Says on July 6, 2017, acquired Complex Care Solutions for approximately $3 million in cash and assumption of a similar amount of debt​.Says‍ expected that acquisition of CCS will contribute an incremental $6 million in revenue during second half of 2017.Says‍ expected that acquisition of CCS will negatively impact adjusted EBITDA by approximately $2.5 million during second half of 2017​.Says‍ company expects acquisition of CCS to be accretive to earnings in 2018​.  Full Article

Amgen enters into agreement with Inovalon and Avalere
Wednesday, 29 Mar 2017 07:55am EDT 

Inovalon Holdings Inc : Amgen enters into agreement with Inovalon and Avalere to engage value-based contracting opportunities . Inovalon Holdings Inc - agreement will focus specifically on Rheumatoid Arthritis (RA) . Inovalon Holdings - Co, Avalere Health will deploy data, analytics capabilities with OBCS to support development of obcs based on value of Amgen's products .Inovalon Holdings - co, Avalere Health, an Inovalon Company, will deploy data, to support further development of OBCS based on value of Amgen's products.  Full Article

Inovalon Q4 non-GAAP earnings per share $0.05
Wednesday, 22 Feb 2017 04:10pm EST 

Inovalon Holdings Inc : Inovalon reports fourth quarter and full year 2016 results . Q4 non-GAAP earnings per share $0.05 . Q4 earnings per share $0.00 . Q4 revenue $96.1 million versus $120.6 million . Sees FY 2017 non-gaap earnings per share $0.28 to $0.31 . Sees FY 2017 earnings per share $0.13 to $0.16 . Sees FY 2017 revenue $440.5 million to $455 million .Inovalon Holdings Inc sees full-year 2017 adjusted EBITDA is expected to be between $105.2 million and $112.5 million.  Full Article

Inovalon announces agreement with Boehringer Ingelheim to support outcome-based contracting
Monday, 23 Jan 2017 07:55am EST 

Inovalon Holdings Inc : Inovalon announces agreement with Boehringer Ingelheim to support outcome-based contracting .Inovalon Holdings Inc - has entered into an agreement with Boehringer Ingelheim Pharmaceuticals Inc.  Full Article

Inovalon Holdings announced a multi-year extension of its partnership with Anthem
Monday, 9 Jan 2017 07:55am EST 

Anthem Inc : Inovalon Holdings Inc- Announced a multi-year extension of its partnership with Anthem, Inc . Inovalon Holdings Inc - Inovalon extends partnership with Anthem .Inovalon Holdings Inc - As part of extended collaboration, Anthem will begin implementation of Inovalon's data diagnostics.  Full Article

Inovalon to acquire Creehan & Company
Thursday, 22 Sep 2016 07:58am EDT 

Inovalon Holdings Inc : Deal for approximately $105 million . Deal results in no change to previously provided 2016 or 2020 financial guidance . Deal includes additional contingent payments of up to $25 million based upon attainment of financial performance objectives through 2018 . Inovalon to acquire Creehan & Company, Industry leading specialty pharmacy SaaS platform . Purchase price will be paid with a combination of available cash and $10 million in restricted stock .Inovalon holdings inc says purchase price will be paid with a combination of available cash and $10 million in restricted stock.  Full Article

Inovalon reports Q2 earnings per share $0.11
Wednesday, 3 Aug 2016 04:10pm EDT 

Inovalon Holdings Inc : Inovalon reports second quarter 2016 results . Q2 earnings per share $0.11 . Q2 earnings per share view $0.14 -- Thomson Reuters I/B/E/S . Sees fy 2016 non-gaap earnings per share $0.39 to $0.46 . Sees fy 2016 revenue $470 million to $490 million . Q2 Non-GAAP earnings per share $0.14 . Q2 revenue $123.8 million versus I/B/E/S view $126.9 million . Sees fy 2016 earnings per share $0.28 to $0.35 .Fy2016 earnings per share view $0.56, revenue view $515.2 million -- Thomson Reuters I/B/E/S.  Full Article